CawachiTSE:2664 -0.88%60 Days Payable is 74.83 as of Mar. 2026, which is 9% above its 10-year median of 68.86. GuruFocus rates TSE:2664 with a GF Score™ of 60/100 and a GF Value™ of 円2,712.70 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Cawachi ranks better than 58.68% on this metric.
Cawachi's average Accounts Payable for the
three
months ended in Mar. 2026 was 円43,775 Mil. Cawachi's Cost of Goods Sold for the
three
months ended in Mar. 2026 was 円53,381 Mil.
Hence, Cawachi's Days Payable for the
three
months ended in Mar. 2026 was 74.83.
The historical rank and industry rank for Cawachi's Days Payable or its related term are showing as below:
TSE:2664'
s Days Payable Range Over the Past 10 Years
Min: 66.78 Med: 68.86 Max: 72.08
Current: 72.08
During the past 13 years, Cawachi's highest Days Payable was 72.08. The lowest was 66.78. And the median was 68.86.
TSE:2664's Days Payable is ranked better than 58.68% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 57.51
vs TSE:2664: 72.08
Cawachi's Days Payable
increased
from Mar. 2025 (72.82) to Mar. 2026 (74.83).
It may suggest that Cawachidelayed paying its suppliers.
Cawachi Days Payable Related Terms
Cawachi Days Payable Historical Data
* Premium members only.
The historical data trend for Cawachi's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Cawachi's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cawachi Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cawachi's Days Payable distribution charts can be found below:
* The bar in red indicates where Cawachi's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cawachi's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cawachi (TSE:2664) has a Days Payable of 74.83 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cawachi and its competitors. This is near median its historical median of 68.86. Over the past decade, Cawachi's Days Payable has ranged from 66.78 to 72.08. According to the industry distribution chart, Cawachi ranks #250 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 41.3%.
Is Cawachi's Days Payable too high?
Cawachi's current Days Payable of 74.83 is near median its 10-year median of 68.86. Over the past 10 years, this metric has ranged from a low of 66.78 to a high of 72.08. The Healthcare Providers & Services industry median Days Payable is 57.51. Cawachi's value of 74.83 is 30.1% above this industry median. Based on the distribution chart, Cawachi ranks #250 out of 605 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cawachi has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cawachi's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Cawachi ranks #250 out of 605 companies for Days Payable. This puts Cawachi in the upper half of its industry. The industry median Days Payable is 57.51. Cawachi's value of 74.83 is 30.1% above this benchmark. Historically, Cawachi's own Days Payable has ranged from 66.78 to 72.08 over the past decade. While the company's 10-year median is 68.86 vs. the industry median of 57.51, Cawachi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.51, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cawachi's current Days Payable of 74.83 is 30.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cawachi and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cawachi's current Days Payable is 74.83, which is near median its own 10-year median of 68.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cawachi stock overvalued right now?
Based on GuruFocus' analysis, Cawachi (TSE:2664) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,712.70, compared to a current price of 円3,360.00 — trading 23.9% above its estimated fair value. The current Days Payable is 74.83, which is near median its 10-year median of 68.86 and 30.1% above the Healthcare Providers & Services industry median of 57.51. Cawachi's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cawachi (TSE:2664), the current Days Payable is 74.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cawachi (TSE:2664) Overvalued in 2026?
Based on GuruFocus' analysis, Cawachi stock appears to be overvalued.
The current stock price of 円3,360.00 is trading 23.9% above its estimated GF Value™ of 円2,712.70.
GuruFocus considers Cawachi to be Modestly Overvalued.
Key valuation signals for TSE:2664:
Days Payable: 74.83 (near median its 10-year median of 68.86)
GF Value™: 円2,712.70 vs. price of 円3,360.00 (23.9% above fair value)
Industry Position: 30.1% above the Healthcare Providers & Services median (#250 of 605)
No single metric tells the full story. See the TSE:2664 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cawachi Ltd is a drug store operator based in Japan. The firm primarily sells pharmaceutical-related products to its customers. It also sells health foods, child care products, cosmetics, grocery, general food and confectionery through its retail outlets. The company operates over 300 stores across Japan.
60GF Score
Get the complete analysis for TSE:2664
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2664 has been successfully added to your 
